14Indexed trials
drug · Product Intelligence
Perampanel
Pipeline Intelligence
Perampanel: 14 indexed trials, 10 sponsors; 1 linked Orange Book patents and 6 FDA-linked events where matched.
10Sponsors
1Orange Book patent links
6FDA-linked events
Development evidence
NCT00368472Eisai Inc. · epilepsyPHASE2
NCT00903786Eisai Co., Ltd. · epilepsyPHASE2
NCT01240187Eisai Inc. · epilepsyPHASE1
NCT01393743Eisai Inc. · epilepsyPHASE3
NCT02427607Eisai Co., Ltd. · epilepsyPHASE3
NCT02727101Mid-Atlantic Epilepsy and Sleep Center, LLC · epilepsyPHASE4
NCT02876289Hospices Civils de Lyon · epilepsyCOMPLETED
NCT03020797Stony Brook University · alsNA
NCT03288129Eisai Inc. · epilepsyPHASE4
NCT03636958Assistance Publique Hopitaux De Marseille · epilepsyNA
NCT03836924Eisai Pharmaceuticals India Pvt. Ltd · epilepsyCOMPLETED
NCT04202159Eisai GmbH · epilepsyCOMPLETED
NCT04257604Eisai Limited · epilepsyCOMPLETED
NCT05274035Beijing Children's Hospital · epilepsyUNKNOWN
FDA / patent evidence
8772497FYCOMPA · app 2028342026-07-01
Regulatory context
FDA_APPROVALPERAMPANEL · 2026-06-15
FDA_EXCLUSIVITYPERAMPANEL · PC2026-06-14
FDA_APPROVALPERAMPANEL · 2025-11-25
FDA_APPROVALPERAMPANEL · 2025-11-25
FDA_APPROVALPERAMPANEL · 2025-07-11
FDA_APPROVALFYCOMPA · 2012-10-22
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.